Eurofins DiscoveryAI: Safe and Secure AI, Custom Data Science, Curated Databases, and Computational Chemistry Solutions

At Eurofins Discovery, we understand that successful drug discovery depends on more than just chemistry and biology expertise. Advanced informatics and data science technology can act as a catalyst to accelerating the journey to ground breaking drug candidates, which is why we have expanded our offering to include Eurofins DiscoveryAI^™ products and services. Our collection of talented computational chemists, medicinal chemists, machine learning engineers, and data scientists bring their unique expertise to deliver cutting-edge solutions that empower client success. In the age of AI, predictive modeling pairs perfectly with experimental data which makes Eurofins Discovery an effective one-stop shop for all your drug discovery needs. Our experts work closely with clients to analyze and interpret complex data sets, leveraging advanced data analytics tools and machine learning algorithms to provide a comprehensive understanding of their data. We offer flexible engagement models, including full-time equivalents (FTEs) and fee-for-service options, to provide clients with the right level of support and expertise to meet their specific needs.
 
Unlock the full potential of your drug discovery pipeline with advanced AI and machine learning tools. Explore our newest product, SAFIRE, a suite of world-class models that combine the power of AI with high-quality proprietary data to provide fast and accurate predictions for ADMET favorability and liability. To compliment our OTS products, we can provide custom advanced data analytics tools that include data visualization tools, predictive models, and smart search engines.
 
Unleash the power of precision with Eurofins Discovery proprietary data sets. With greater than 1 million experimental datapoints composed of time-tested, currently available assays, the EMERALD database is unrivaled in quality and depth. EMERALD is a gateway to predicting the vast chemical landscape and licensing this elite data set can provide clients with rich and relevant data to support internal model development.
 
We also offer a range of computational chemistry services including molecular modeling, virtual screening, and ligand-based and structure-based drug design to help clients make informed decisions in the drug discovery process. Our advanced in-silico techniques ensure our clients stay ahead in the competitive landscape by enabling rapid identification and optimization of lead compounds to drastically improve the quality of hits compared to traditional methods.
 
Our Eurofins DiscoveryAI products and services are designed to provide clients with valuable insights into their drug candidates, allowing them to make better-informed decisions with the highest quality data. We tailor our solutions to the specific needs of each client, and we can customize them to meet unique requirements. By partnering with Eurofins Discovery, clients gain access to a global leader with our 40-plus years of experience in drug discovery, delivering quality, efficiency, and cost-effectiveness for drug discovery programs.